Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
Condition(s):Neuropathic PainLast Updated:August 25, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Neuropathic PainLast Updated:August 25, 2017Terminated
Condition(s):Psychomotor Agitation; Schizophrenia; Bipolar DisorderLast Updated:November 4, 2019Not yet recruiting
Condition(s):Agitation,PsychomotorLast Updated:July 30, 2019Recruiting
Condition(s):AgitationLast Updated:October 3, 2019Recruiting
Condition(s):Patients With Schizophrenia and Acute AgitationLast Updated:June 28, 2017Completed
Condition(s):AsthmaLast Updated:March 13, 2017Completed
Condition(s):Agitation,Psychomotor; Haloperidol Causing Adverse Effects in Therapeutic Use; Lorazepam Causing Adverse Effects in Therapeutic Use; Loxapine Causing Adverse Effects in Therapeutic UseLast Updated:May 11, 2018Terminated
Condition(s):Smoking, CigaretteLast Updated:March 13, 2017Completed
Condition(s):MigraineLast Updated:June 13, 2017Completed
Condition(s):BiPolarLast Updated:February 26, 2016Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:March 13, 2017Completed
Condition(s):RestlessnessLast Updated:July 17, 2014Completed
Condition(s):SchizophreniaLast Updated:May 30, 2017Completed
Condition(s):Bipolar I DisorderLast Updated:June 28, 2017Completed
Condition(s):HealthyLast Updated:November 18, 2018Completed
Condition(s):Migraine HeadacheLast Updated:March 13, 2017Completed
Condition(s):Volunteers on Chronic, Stable Antipsychotic RegimensLast Updated:March 13, 2017Completed
Condition(s):Acute Agitated PatientsLast Updated:March 10, 2015Terminated
Condition(s):SchizophreniaLast Updated:November 17, 2018Completed
Condition(s):Respiratory Insufficiency; Psychomotor AgitationLast Updated:July 20, 2007Completed
Condition(s):HealthyLast Updated:March 31, 2008Completed
Condition(s):Thorough QT/QTc StudyLast Updated:October 29, 2019Completed
Condition(s):Healthy VolunteersLast Updated:September 26, 2017Completed
Condition(s):Healthy VolunteersLast Updated:November 15, 2017Completed
Condition(s):AgitationLast Updated:August 23, 2016Unknown status
Condition(s):Agitation,PsychomotorLast Updated:July 27, 2016Completed
Condition(s):CardiotoxicityLast Updated:November 19, 2018Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:August 8, 2018Active, not recruiting
Condition(s):SchizophreniaLast Updated:December 21, 2017Unknown status
Condition(s):Psychotic Disorders; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Diabetes Mellitus, Type 2Last Updated:October 20, 2015Completed
Condition(s):SchizophreniaLast Updated:January 21, 2019Completed
Condition(s):Delirium; AgitationLast Updated:August 2, 2012Terminated
Condition(s):Obesity; Weight Gain; Psychotropic Induced Weight GainLast Updated:December 28, 2018Completed
Condition(s):StrokeLast Updated:August 8, 2019Completed
Condition(s):MigraineLast Updated:January 26, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.